benzofuran has been researched along with Asthma, Bronchial in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aierken, A; Xu, P | 1 |
Ahn, KS; Harmalkar, DS; Jeong, HG; Kwon, OK; Lee, G; Lee, K; Lim, Y; Lu, Q; Mali, JR; Oh, SR; Shin, IS; Xu, X | 1 |
Ando, K; Kohno, S; Kunitomo, J; Ohishi, Y; Ohta, S; Tsuji, E; Yamashita, M | 1 |
3 other study(ies) available for benzofuran and Asthma, Bronchial
Article | Year |
---|---|
Bacterial respiratory tract inflammation in neonatal rat model is attenuated by benzofuran through inhibition of GATA3.
Topics: Animals; Anti-Asthmatic Agents; Asthma; Benzofurans; Bronchoconstrictor Agents; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; GATA3 Transcription Factor; Histocytochemistry; Inflammation; Lung; Methacholine Chloride; Rats; Serum; Treatment Outcome | 2018 |
Novel benzofuran derivative DK-1014 attenuates lung inflammation via blocking of MAPK/AP-1 and AKT/mTOR signaling in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Benzofurans; Cells, Cultured; Cytokines; Disease Models, Animal; Humans; Macrophages; Mice; Mice, Inbred BALB C; Nitric Oxide; Pneumonia; Proto-Oncogene Proteins c-akt; Respiratory Mucosa; Signal Transduction; TOR Serine-Threonine Kinases; Transcription Factor AP-1 | 2019 |
Preparation of 3-acetoacetylaminobenzo[b]furan derivatives with cysteinyl leukotriene receptor 2 antagonistic activity.
Topics: Asthma; Benzofurans; Chemistry, Organic; Crystallography, X-Ray; Humans; Leukotriene Antagonists; Membrane Proteins; Models, Chemical; Models, Molecular; Receptors, Leukotriene | 2003 |